Undervalued Small-Cap Stocks on NYS May 2025

May 12, 2025

New York Stock Exchange

The New York Stock Exchange, located in New York City, is the largest securities exchange in the world by market capitalization of its listed companies.

Small, Micro and Nano-Cap

Stocks in the Small, Micro and Nano Market Cap groups have a market capitalization of less than $2 billion.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued stocks on the NYS

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
HWKZ Hawks Acquisition 10.26 10.03 -2.26 2544 295 0.00 93.3
AACT Ares Acquisition - - 0.00 - 0 0.00 26.9
AAP Advance Auto Parts - - 0.00 - 0 3.00 0.0
ABR Arbor Realty Trust - - 0.00 - 0 16.00 10.4
ACCO ACCO Brands - - 0.00 - 0 7.73 0.0
ADCT ADC Therapeutics - - 0.00 - 0 0.00 0.0
ADNT Adient - - 0.00 - 0 0.00 0.0
AEG Aegon - - 0.00 - 0 5.16 16.2
AER AerCap Holdings - - 0.00 - 0 0.92 9.9
AG First Majestic Silver - - 0.00 - 0 0.32 0.0
All data provided as at market close July 10, 2023.

Company Details

Hawks Acquisition

HWKZ:NYS

Close Price

10.26

Our Valuation

10.03

% Difference

-2.26

Market Cap ($M)

295

P/E Ratio

93.3

Hawks Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, consolidation, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Access the stockcalc valuation


Ares Acquisition

AACT:NYS

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

26.9

Ares Acquisition Corp II is a blank check company.

Access the stockcalc valuation


Advance Auto Parts

AAP:NYS

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

Advance Auto Parts is a leading auto-parts retailer in North America with more than 4,000 store and branch locations. About 50% of the firm's sales are geared toward the professional channel, with the remaining sales in the do-it-yourself market. Through its vast store footprint and distribution network, Advance manages thousands of stock-keeping units for various vehicle makes and models.

Access the stockcalc valuation


Arbor Realty Trust

ABR:NYS

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

10.4

Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

ACCO Brands

ACCO:NYS

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through two segments: ACCO Brands Americas, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses.

Access the stockcalc valuation


ADC Therapeutics

ADCT:NYS

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy.

Access the stockcalc valuation


Adient

ADNT:NYS

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is the leading seating supplier to the industry with about one third of the global market. Its share in China is now nearly 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.8 billion in fiscal 2024 and consolidated China revenue was $1.4 billion.

Access the stockcalc valuation


Aegon

AEG:NYS

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

16.2

Aegon is a life insurance and long-term savings business listed in the Netherlands. It listed on the Amsterdam Stock Exchange in the 1980s and now has mature operations in the United States, United Kingdom, and four growth markets of Brazil, China, Portugal, and Spain. Over recent years, Aegon has been moving through an extensive transformation program where management has sought to divest noncore operations and improve the risk profile of the business.

Access the stockcalc valuation


AerCap Holdings

AER:NYS

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

9.9

AerCap Holdings NV is an aircraft leasing company. Its activities include leasing, financing, sales, and management of commercial aircraft and engines. It also provides aircraft asset management and corporate services to securitization vehicles, joint ventures, and other third parties.It has one business segment: leasing, financing, sales and management of commercial flight equipment (Commercial Flight Equipment Segment).

Access the stockcalc valuation


First Majestic Silver

AG:NYS

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

First Majestic Silver Corp is engaged in the production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. It owns three producing mines in Mexico consisting of the San Dimas Silver/Gold Mine, the Santa Elena Silver/Gold Mine, and the La Encantada Silver Mine.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Hawks Acquisition and Ares Acquisition are the most undervalued Small-Cap stocks on the NYS. See which other companies made the list here: https://www.stockcalc.com/Blog/undervalued-small-cap-stocks-nys-may-2025
Hawks Acquisition $HWKZ and Ares Acquisition $AACT are the most undervalued Small-Cap stocks on the #NYS. See the full list here: https://www.stockcalc.com/Blog/undervalued-small-cap-stocks-nys-may-2025
Hawks Acquisition and Ares Acquisition are the most undervalued Small-Cap stocks on the NYS. See which other companies made the list here: https://www.stockcalc.com/Blog/undervalued-small-cap-stocks-nys-may-2025

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.